News | October 03, 2024
CCI approves acquisition of Bharat Serums and Vaccines by Mankind Pharma
The transaction involves the acquisition of 100% shareholding of Bharat Serums and Vaccines (BSV) by Mankind Pharma
The transaction involves the acquisition of 100% shareholding of Bharat Serums and Vaccines (BSV) by Mankind Pharma
The acquisition of LumiraDx’s Point of Care technology received all required antitrust and regulatory clearances
Emraclidine, a potential best-in-class, next-generation antipsychotic, is in trials designed to be registration enabling for schizophrenia
This transaction is the third acquisition by three different Japanese players in this segment
Acquisition strengthens and diversifies Merck’s pipeline with the addition of Restoret
Protein research is key to advancing our understanding of human biology and delivering on the promise of precision medicine
Shares and American Depositary Shares of Olink for $26.00 per Share
Felzartamab demonstrated positive interim results from the Phase 2 IgA nephropathy (IgAN) study
This plant is located at Baddi, Himachal Pradesh spread over an area of 2.85 acres
The transaction aligns with Lupin's strategy to grow its global presence in Specialty areas
Subscribe To Our Newsletter & Stay Updated
